US2019079104A1PendingUtilityA1
Diagnostic method for urinary tract infection
Est. expiryFeb 7, 2031(~4.6 yrs left)· nominal 20-yr term from priority
C07K 2317/33G01N 2800/348A61P 13/02G01N 2400/40G01N 33/569A61K 45/06G01N 33/6893C07K 16/18
57
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.
Claims
exact text as granted — not AI-modified1 - 14 . (canceled)
15 . A method of identifying whether an individual has a urinary tract infection (UTI), comprising:
measuring the level of Heparin Binding Protein (HBP, CAP37, Azuricidin) in a urine sample obtained from an individual by; (i) contacting the sample with an antibody which binds specifically to HBP; and (ii) quantitating the amount of antibody-HBP complex to measure the HBP level in the urine sample; and detecting the presence of UTI in the individual at about 93% Sensitivity or greater and at about 90% Specificity or greater based on the measured HBP level in the urine sample.
16 . The method of claim 15 , wherein the individual is a mammal.
17 . The method of claim 16 , wherein the mammal is a human.
18 . The method of claim 17 , wherein the detecting of UTI at about 93% Sensitivity or greater and at about 90% Specificity or greater is determined by a Receiver Operating Characteristic (ROC).
19 . The method of claim 17 , wherein the 93.3% Sensitivity and the 90.3% Specificity for detecting UTI is a threshold value of about 32 ng/ml in the urine sample.
20 . The method of claim 15 , wherein the binding of the antibody to HBP is measured by enzyme linked immunosorbent assay (ELISA).
21 . The method of claim 15 , wherein the binding of the antibody to HBP is measured using a dipstick assay.
22 . The method of claim 15 , wherein the urinary tract infection is lower urinary tract infection or pyelonephritis.
23 . The method of claim 15 , further comprising determining the white blood cell count or the level of IL6 in a urine sample from the individual, or conducting the nitrite test on a urine sample from the individual.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.